HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
iBio, Inc. (IBIO)
2.08  -0.14  (-6.31%) 07-02 01:09
Open: 2.03 High: 2.12
Pre.close: 2.22 Low: 1.85
Volume: 19,559,323 Ave vol: 14,897,538
52w High: 3.4 52w Low: 0.05
MA(50): 1.571 MA(200): 0.976
EPS: -0.975 P/E Ratio: 0
Company profile
Exchange: AMEX
Sector: Healthcare
Industry: Biotechnology
Website: http://www.ibioinc.com
Market Cap (M): 249
Shares Out (M): 120
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of pre-clinical development, regulatory approval, commercial product launch, and on-going commercial phase requirements. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. The company is also developing vaccine candidates for third parties. It has a license agreement with the University of Natural Resources and Life Sciences, Vienna; a strategic relationship with Beijing CC-Pharming Ltd.; and collaboration agreements with AzarGen Biotechnologies (Pty) Ltd, The Texas A&M University System, and Fraunhofer Center for Molecular Biotechnology. In addition, the company offers a range of product and process development, analytical, and manufacturing services. iBio, Inc.
Technical analysis
Overall: Underperform
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bearish
Target 1: 3.15 Target 2: 3.68
Resist 1: 2.70 Resist 2: 3.15
Support 1: 1.88 Support 2: 1.38
Company key metrics
Revenue per Share: 0.1066
Net Income per Share: -0.9296
Cash per Share: 0.2336
Book Value per Share: 0.1301
Price to Sales: 6.4712
Price to Book Value: 5.302
Earnings Yield: -1.3472
Dividend Yield: 0
Debt to Equity: 11.4182
Debt to Assets: 0.9195
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Wed, 01 Jul 2020
Market Reactions to Ibio Inc (IBIO) Stock Getting a Neutral Rating - InvestorsObserver

Mon, 29 Jun 2020
Is Ibio Inc (IBIO) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Fri, 26 Jun 2020
iBio to be Added to the Russell 2000® and Russell 3000® Indexes - GlobeNewswire

Tue, 30 Jun 2020
iBio Inc. (AMEX:IBIO) Stock is Soaring, Here is Why - The Oracle Dispatch

Thu, 04 Jun 2020
iBio Announces Second COVID-19 Vaccine Program NYSE:IBIO - GlobeNewswire

Wed, 24 Jun 2020
Is Ibio Inc (IBIO) Stock About to Get Hot Wednesday? - InvestorsObserver

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.